Erste Asset Management Gmb H Aprea Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

$8.35 Trillion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Nov 22, 2024	SELL	$4.73 - $8.15 $165,550 - $285,250	-35,000 Closed	0 $0
Q3 2020 Nov 22, 2024	BUY	$21.66 - $38.86 $758,100 - $1.36 Million	35,000 New	35,000 $792 Million
Q2 2020 Nov 22, 2024	BUY	$25.47 - $39.69 $229,230 - $357,210	9,000 Added 34.62%	35,000 $1.28 Billion
Q1 2020 Nov 22, 2024	BUY	$31.65 - $45.3 $822,900 - $1.18 Million	26,000 New	26,000 $871 Million

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,813
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.